Skip to content

Prozac and Amazon’s latest move in physical stores

*

Johnson & Johnson get some good news

Johnson & Johnson got some good news for a change as its antidepressant drug, called esketamine and branded Spravato, was fast-tracked through the FDA approval process and is now the first antidepressant to get approval since Prozac 30 years ago.

The nasal spray has to be administered by doctors and monitored for a couple of hours afterwards to check for side-effects, but tests have shown that it can have a positive effect very quickly – sometimes within two days.

This could be fantastic news for a third of those who suffer major depressive disorders and who don’t respond to existing therapies and it will only be administered to those for whom the existing treatments don’t work.

On a related note, Allergan, a Dublin-based pharmaceutical company, will soon announce the results of phase III trials of Rapastinel, its antidepressant drug based on similar principles.

Amazon’s latest move in physical stores

The other thing I wanted to talk about today was Amazon’s latest moves in physical stores. The company announced that it was going to close down its 87 US pop-up stores which showcased devices like its Echo, Kindles and other new products.

On the other hand, it plans to expand the number of bookstores and its “4-star stores” which stock products with 4 star ratings and above.

You will also recall that the company announced the other day that it was going to roll out a new line of grocery stores and more Amazon Go cashierless outlets.

Not being content with crushing retailers online, the company is now focusing its attention on the high street.

I am sure that the pop-ups will have been a useful research tool for Amazon, but I think it’s getting serious now about physical stores and retailers should be getting very worried.

Share this article

Invest with these platforms

Hargreaves Lansdown IG Interactive Brokers Interactive Investor Charles Stanley
IG Interactive Brokers Charles Stanley

Looking for great investing ideas? Sign up to our free newsletter.

Join our UK news channel on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Admiral Markets

TMX
WisdomTree
ARK
FxPro
CMC Markets
Back To Top